Author: Carly Behm

Since the COVID-19 pandemic began nearly two years ago, spine and orthopedic specialties have made major shifts in how care is delivered. As 2021 ends, spine and orthopedic leaders are thinking about what to expect next year.

Los Angeles-based FullRange Spine & Ortho began offering regenerative treatments using a patient's own stem cells.

Safe Orthopaedics' Sycamore implant for spinal fractures was found to be "very satisfactory," according to three-month clinical data released by the company.

Palm Beach Gardens, Fla.-based American Orthopedic Partners has added two partnerships in New Jersey.

Alex Bateman, CEO of Atlanta-based Resurgens Orthopaedics, is laying the groundwork for an optimistic 2022. Mr. Bateman will be at the helm of an orthopedic platform that was announced Dec. 9.

Bioventus' Nexus BoneScalpel Access handpiece was cleared by the FDA.

Here are 45 orthopedic surgeons who moved to new practices in 2021:

Here are 39 spine surgeons who moved to new practices in 2021:

Pfizer's Xeljanz drug was approved by the FDA to treat active ankylosing spondylitis in adults.

The American Academy of Orthopaedic Surgeons updated its clinical practice guidelines for hip fractures in older adults.